Australian Super Pty LTD Bristol Myers Squibb CO Transaction History
Australian Super Pty LTD
- $20.5 Billion
- Q3 2025
A detailed history of Australian Super Pty LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Australian Super Pty LTD holds 2,361,163 shares of BMY stock, worth $111 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
2,361,163
Previous 2,361,163
-0.0%
Holding current value
$111 Million
Previous $106 Million
-0.0%
% of portfolio
0.52%
Previous 0.51%
Shares
24 transactions
Others Institutions Holding BMY
# of Institutions
2,682Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...